Tag: Marty Makary

UniQure to seek FDA approval for Huntington’s disease gene therapy after previous clash with agency

FDA shuffles top drug, biologics leaders in latest shakeup

FDA commissioner defends agency’s drug approval decisions after wave of backlash

FDA fast-tracks psychedelic drug research following Trump executive order

FDA vaccine head will step down in April after string of controversial decisions

FDA reversals leave investors worrying about the fates of other experimental drugs

FDA official calls UniQure’s gene therapy a ‘failed’ treatment for Huntington’s disease

FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals

FDA chief Marty Makary says ‘everything should be over-the-counter’ unless drug is unsafe or addictive